Caitong International Asset Management’s Standard BioTools LAB Stock Holding History

Caitong International Asset Management’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Hold	1	–	–	﹤0.01%	2881
2026 Q1	$1	Sell	1 -164	-99%	-$199	﹤0.01%	2488
2025 Q4	$211	Buy	+165	New	+$222	﹤0.01%	1611
2025 Q3	–	Sell	-1,932	Closed	-$2.32K	–	2248
2025 Q2	$2.32K	Buy	+1,932	New	+$2.14K	﹤0.01%	1332

Other funds holding LAB

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Caitong International Asset Management's LAB Position: Q2 2026 in Review

Caitong International Asset Management held its Standard BioTools (LAB) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2881.

Caitong International Asset Management first reported a position in LAB in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.32K in Q2 2025. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

Caitong International Asset Management held 1 share of Standard BioTools worth $1 as of Q2 2026.
Caitong International Asset Management left its Standard BioTools share count unchanged in Q2 2026.
Standard BioTools made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2881 holding.
Caitong International Asset Management first reported a position in Standard BioTools in Q2 2025 and has held it in 4 quarters since.
Caitong International Asset Management's Standard BioTools position peaked at $2.32K in Q2 2025.
144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.